A recent review considers a potential link between unexpected drug toxicities and patient adherence in clinical trials and asks: how safe is the prescribed dose for some drugs now on the market?

A recent review considers a potential link between unexpected drug toxicities and patient adherence in clinical trials and asks: how safe is the prescribed dose for some drugs now on the market?